{{Rsnum
|rsid=7585356
|Gene=BARD1
|Chromosome=2
|position=214727582
|Orientation=plus
|GMAF=0.2759
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene_s=BARD1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 10.6 | 46.0 | 43.4
| HCB | 13.9 | 42.3 | 43.8
| JPT | 9.7 | 35.4 | 54.9
| YRI | 1.4 | 19.7 | 78.9
| ASW | 3.5 | 36.8 | 59.6
| CHB | 13.9 | 42.3 | 43.8
| CHD | 18.3 | 53.2 | 28.4
| GIH | 15.8 | 51.5 | 32.7
| LWK | 0.0 | 18.2 | 81.8
| MEX | 10.3 | 34.5 | 55.2
| MKK | 1.3 | 20.6 | 78.1
| TSI | 6.9 | 39.2 | 53.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23222812
|Title=Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility
|OA=1
}}

{{PMID Auto
|PMID=19412175
|Title=Common variations in BARD1 influence susceptibility to high-risk neuroblastoma.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}